Axsome Therapeutics, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AXSM Nasdaq 2830 www.axsome.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Axsome Therapeutics, Inc.

Should You Buy Axsome Therapeutics Stock Before Feb. 23? - Feb 5th, 2026 7:20 am
The Bull Case For Axsome Therapeutics (AXSM) Could Change Following Strong Auvelity Sales And Alzheimer’s Label Hopes - Feb 4th, 2026 10:13 am
1 High-Flying Stock With More Upside Ahead - Feb 3rd, 2026 10:05 am
Axsome Therapeutics (AXSM) Reports 66% Revenue Growth in FY2025, Beats Analyst Estimates - Feb 3rd, 2026 4:55 am
Axsome Therapeutics AXS-05 Alzheimer's Launch Could Drive Upside, RBC Says - Feb 2nd, 2026 10:09 am
Axsome Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 23 - Jan 27th, 2026 5:00 am
Auvelity Continues to Aid AXSM's Top Line: More Upside in 2026? - Jan 26th, 2026 8:15 am
How The New Price Target Is Shaping The Axsome Therapeutics (AXSM) Investment Story - Jan 23rd, 2026 2:10 pm
Assessing Axsome Therapeutics (AXSM) Valuation After Analyst Upgrades And Pipeline Progress - Jan 23rd, 2026 5:11 am
Top Picks 2026- Axsome Therapeutics Inc. AXSM - Jan 22nd, 2026 10:01 pm
Piper Sandler Bullish on Axsome Therapeutics (AXSM) Ahead of Likely Auvelity Label Expansion by April 30 - Jan 22nd, 2026 7:52 pm
Strength Seen in Axsome (AXSM): Can Its 4.1% Jump Turn into More Strength? - Jan 21st, 2026 6:18 am
Axsome Therapeutics Begins Phase III Study on AXS-14 for Fibromyalgia - Jan 16th, 2026 9:15 am
Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia - Jan 15th, 2026 5:00 am
Is Axsome Therapeutics (AXSM) Pricing Reflect Long Term Growth After Pipeline Milestones And 90% Rally - Jan 12th, 2026 6:08 pm
Axsome Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue - Jan 12th, 2026 5:00 am
HALO or AXSM: Which Is the Better Value Stock Right Now? - Jan 9th, 2026 9:40 am
Biotech Is Heating Up—These 2 Red-Hot Stocks Stand Out - Jan 8th, 2026 6:23 am
2 Healthcare Stocks to Buy for 2026 and Beyond - Jan 8th, 2026 3:35 am
Why Axsome Therapeutics (AXSM) Is Up 17.5% After Dual FDA Boosts For AXS-05 And AXS-12 – And What's Next - Jan 4th, 2026 9:23 pm